Advancements in the identification of adducts of drug-human serum albumin
The covalent binding of drugs and their metabolites to proteins forms drug-protein adducts,which may cause adverse reactions in the body.The development of adductomics technology is helpful for the identification of covalent adducts between drugs and human plasma proteins.For many drugs,such as beta-lactam antibiotics,acyl glucuronides,covalent tyrosine kinases inhibitors,and reactive metabolites,human serum albumin(HSA)is a potential target and biomarker for the formation of drug-protein adducts.In this review,we will describe the relevant technical advances,describe the methods for the identification of covalent adducts of drugs and HSA,define the chemical reactions that form adducts,and preliminarily explore the role of drug-HSA adducts in adverse drug reactions and the potential effect on pharmacokinetics.
human serum albumincovalent adductadductomicsadverse drug reactionpharmacokinetics
NETL
NSTL
万方数据
